Synergy Pharmaceuticals, Inc. Watch

from 8-K 88 pages Amended and Restated Asset Purchase Agreement by and Among Synergy Pharmaceuticals Inc., Synergy Advanced Pharmaceuticals, Inc., Bausch Health Companies Inc. and Bausch Health Ireland Limited Dated as of January 4, 2019

from 8-K 87 pages Asset Purchase Agreement by and Among Synergy Pharmaceuticals Inc., Synergy Advanced Pharmaceuticals, Inc., Bausch Health Companies Inc. and Bausch Health Ireland Limited Dated as of December 11, 2018

from 10-K 1 page Plan of reorganization, merger, acquisition or similar

from 425 6 pages Amendment No. 1 to Agreement and Plan of Merger

from 8-K 6 pages Amendment No. 1 to Agreement and Plan of Merger

from 8-K 58 pages Agreement and Plan of Merger by and Between Synergy Pharmaceuticals Inc. and Callisto Pharmaceuticals, Inc. Dated as of July 20, 2012 Agreement and Plan of Merger

from 425 58 pages Agreement and Plan of Merger by and Between Synergy Pharmaceuticals Inc. and Callisto Pharmaceuticals, Inc. Dated as of July 20, 2012 Agreement and Plan of Merger

from 10-K 4 pages Agreement and Plan of Merger

from 8-K ~5 pages Reference Is Hereby Made to That Exchange Agreement, (The “Agreement”) Executed and Dated July 11, 2008 (The “Agreement”), Among Callisto Pharmaceuticals, Inc., a Delaware Corporation (“Callisto”), Synergy Pharmaceuticals, Inc., a Delaware Corporation (“Synergy”), the Individual Parties Named on the Signature Page Hereto (The “Synergy Holders”) on the One Hand, and Pawfect Foods, Inc., a Florida Corporation (The “Company”), on the Other Hand. Capitalized Terms Herein Unless Otherwise Defined, Shall the Meanings Assigned to Them in the Agreement

from 8-K 28 pages Exchange Agreement